GAROFALO ELIZABETH A. exercised options at ACADIA PHARMACEUTICALS INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/1/2026ACC: 0001826361-26-000002
Director
Since Sep 2020
+25.32K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
33.42K acquired · 8.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.11K
Price / share
—
Trade value
—
% of position
31.9%
5/29/2026
25.38K→33.49K
Total
Net shares
+8.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | M · Option Exercise | +8.11K | — | — | 31.9% | 25.38K | 33.49K |
| Total | +8.11K | $0.00 | ||||||
Derivative Transactions3
Restricted Stock Units
Direct
Converts to
Common Stock
8.11K shares
Shares
−8.11K
Strike price
Held after
0.00
Exercisable
—
5/29/2026
Director Stock Options (Right to Buy)
Direct
Converts to
Common Stock
16K shares
Shares
+16K
Strike price
21.66
Held after
16K
Exercisable
—
5/29/2026
Restricted Stock Units
Direct
Converts to
Common Stock
9.31K shares
Shares
+9.31K
Strike price
Held after
9.31K
Exercisable
—
5/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock8.11K shares | 5/29/2026 | M · Option Exercise | −8.11K | — | 0.00 | |
| Director Stock Options (Right to Buy) Direct | Common Stock16K shares | 5/29/2026 | A · Award | +16K | 21.66 | — | 16K |
| Restricted Stock Units Direct | Common Stock9.31K shares | 5/29/2026 | A · Award | +9.31K | — | 9.31K |